1. Skin cancer symptoms: Three potential warning signs you may have developed the disease
SKIN CANCER - considering the heatwave Britain has been experiencing, people need to protect themselves. Increased sun exposure can lead to sun damage. There are three potential warning signs that you've developed the disease. more details...


2. A new way to monitor skin cancer: Scientists suggest a urine test could help track progression and treatment response
Skin cancer is the most common form of cancer in the United States, United Kingdom and worldwide. The success rate of the treatment is usually directly proportional to early detection and even then, the course of treatment requires a multi-directional approach as there is no single, effective treatment for it. more details...


3. FDA Approves Genentech's Tecentriq, Cotellic, Zelboraf for BRAF V600-Mutated Melanoma
The US Food and Drug Administration on Thursday approved the combination of three Genentech drugs, the immune checkpoint inhibitor atezolizumab (Tecentriq), the MEK inhibitor cobimetinib (Cotellic), and the BRAF inhibitor vemurafenib (Zelboraf), for the treatment of BRAF V600-mutated advanced melanoma. more details...


4. Adjuvant dabrafenib-trametinib provides ‘real chance to cure’ BRAF-mutant melanoma
Adjuvant dabrafenib and trametinib provided long-term benefit for patients with resected stage III BRAF V600-mutant melanoma, according to an analysis of the COMBI-AD trial presented during the ASCO20 Virtual Scientific Program. more details...


5. FDA approval for Novartis' melanoma combo
The FDA has approved Novartis' Tafinlar(dabrafenib) in combination with Mekinist (trametinib) for the adjuvant treatment of BRAF V600E or V600K mutation-positive melanoma, as detected by an FDA-approved test, and involvement of lymph nodes, following complete resection. more details...